Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Nedosiran population pharmacokinetic and pharmacodynamic modelling and simulation to guide clinical development and dose selection in patients with primary hyperoxaluria type 1.
Journal: British journal of clinical pharmacology
Published: March 27, 2024
Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V.
Journal: Bone
Published: September 28, 2020
Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN.
Journal: Case reports in neurological medicine
Published: November 24, 2016
Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology
Published: October 02, 2015
Recombinant Enzyme Replacement Therapy in Hypophosphatasia.
Journal: Sub-cellular biochemistry
Published: July 30, 2015
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: August 10, 2013
Hypophosphatasia - pathophysiology and treatment.
Journal: Actualizaciones en osteologia
Published: September 01, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026